CBT for Depression in Primary Care: Gold Standard, or One Option Among Many?

Why It Matters

The results question the entrenched view of CBT as the sole gold‑standard for depression in primary care, prompting clinicians and payers to consider a broader array of evidence‑based options. This shift could reshape treatment guidelines, reimbursement policies, and resource allocation toward more personalized care.

Key Takeaways

• CBT reduces depressive symptoms modestly versus inactive controls (g=0.44).
• No clear advantage of CBT over other active therapies.
• Face‑to‑face and computerised CBT show similar small effects.
• Self‑help CBT shows limited benefit in primary‑care settings.

Pulse Analysis

Depression remains one of the most common mental‑health challenges, and the majority of patients first seek help in primary‑care settings. Because CBT has long been championed as the "gold standard," it dominates clinical guidelines and training programs, often receiving preferential funding. Yet the landscape of psychological interventions is expanding, with digital platforms, brief behavioural activation protocols, and other psychotherapies gaining traction. Understanding how these options perform in real‑world primary‑care environments is essential for delivering cost‑effective, patient‑centred care.

The meta‑analysis of 44 trials reveals that CBT, behavioural activation and cognitive therapy do improve depressive symptoms compared with inactive controls, but the benefit is modest (effect size around 0.44). When pitted against other active treatments—ranging from alternative talking therapies to medication and exercise—CBT does not demonstrate a statistically significant edge. Notably, individual face‑to‑face sessions and therapist‑supported computerised programmes produce comparable outcomes, suggesting that digital delivery can safely broaden access without sacrificing efficacy. Conversely, self‑help CBT, often promoted for milder cases, showed limited impact, highlighting the need for clinician oversight in such formats.

For practitioners, the takeaway is clear: a flexible, person‑centred toolbox outweighs a one‑size‑fits‑all reliance on CBT. Policymakers should reconsider reimbursement models that privilege CBT exclusively and instead support a spectrum of validated interventions, including digital and group‑based formats. Future research must address long‑term outcomes beyond one year and directly compare CBT with other active modalities to refine the evidence base. Embracing this nuanced view can improve treatment matching, reduce unnecessary costs, and ultimately enhance recovery rates for millions of patients navigating depression in primary care.